Intention to pursue genetic testing for breast cancer among women due for screening mammography.
暂无分享,去创建一个
[1] Katrina Armstrong,et al. Interest in BRCA1/2 testing in a primary care population. , 2002, Preventive medicine.
[2] W. Burke,et al. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. , 2001, American journal of medical genetics.
[3] J. Struewing,et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. , 2000, American journal of medical genetics.
[4] R M Groves,et al. Consequences of reducing nonresponse in a national telephone survey. , 2000, Public opinion quarterly.
[5] P. Devilee,et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.
[6] M P Osborne,et al. Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. , 2000, Seminars in surgical oncology.
[7] S. Taplin,et al. Women's knowledge and attitudes about genetic testing for breast cancer susceptibility. , 1999, Effective clinical practice : ECP.
[8] I. Lipkus,et al. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] J. Allanson,et al. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer , 1999, Clinical genetics.
[10] H T Lynch,et al. Genetic testing in families with hereditary nonpolyposis colon cancer. , 1999, JAMA.
[11] D. Bowen,et al. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] C. Isaacs,et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. , 1997, Patient education and counseling.
[13] M. Schwartz,et al. The influence of psychological distress on use of genetic testing for cancer risk , 1997 .
[14] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[15] C. Richards,et al. Screening for 185delAG in the Ashkenazim. , 1997, American journal of human genetics.
[16] A S Whittemore,et al. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.
[17] B. Rimer,et al. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. , 1997, American journal of medical genetics.
[18] M. Andrykowski,et al. Interest in learning of personal genetic risk for cancer: a general population survey. , 1996, Preventive medicine.
[19] B. Trock,et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.
[20] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[21] W J Hall,et al. Women's receptivity to testing for a genetic susceptibility to breast cancer. , 1995, American journal of public health.
[22] C. Lerman,et al. Interest in genetic testing among first-degree relatives of breast cancer patients. , 1995, American journal of medical genetics.
[23] J. Struewing,et al. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[24] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[25] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[26] M. Hayden,et al. Predictive testing for Huntington disease. , 1992, Journal of medical ethics.
[27] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[28] B. Trock,et al. Psychological and behavioral implications of abnormal mammograms. , 1991, Annals of internal medicine.
[29] B. Trock,et al. Factors associated with repeat adherence to breast cancer screening. , 1990, Preventive medicine.
[30] D. Craufurd,et al. UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE , 1989, The Lancet.
[31] J. Fraumeni,et al. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. , 1982, Journal of the National Cancer Institute.
[32] H. Adami,et al. Characteristics of familial breast cancer in sweden: Absence of relation to age and unilateral versus bilateral disease , 1981, Cancer.
[33] F. Speizer,et al. Family history of breast cancer as a risk indicator for the disease. , 1980, American journal of epidemiology.
[34] D. Dillman. Mail and telephone surveys : the total design method , 1979 .
[35] Pamela A Ratner,et al. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[36] Ahmedin Jemal,et al. Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.
[37] D. Makuc,et al. Urban and rural health chartbook , 2001 .
[38] L. Caplan,et al. Trends in mammography use and their relation to physician and other factors. , 1996, Cancer detection and prevention.
[39] M. Morris,et al. Reluctance to undergo predictive testing: the case of Huntington disease. , 1993, American journal of medical genetics.
[40] A. Miller,et al. Is routine mammography screening appropriate for women 40-49 years of age? , 1991, American journal of preventive medicine.
[41] S. Fox,et al. The impact of physician compliance on screening mammography for older women. , 1991, Archives of internal medicine.
[42] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.